Home > Products > CD44 & CR3
> Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG)
Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-121)
Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD44 and anti-CR3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG) (BSIG-121). Click the button below to contact us or submit your feedback about this product.